232 related articles for article (PubMed ID: 28368394)
1. Inhibition of cyclooxygenase-2-mediated matriptase activation contributes to the suppression of prostate cancer cell motility and metastasis.
Ko CJ; Lan SW; Lu YC; Cheng TS; Lai PF; Tsai CH; Hsu TW; Lin HY; Shyu HY; Wu SR; Lin HH; Hsiao PW; Chen CH; Huang HP; Lee MS
Oncogene; 2017 Aug; 36(32):4597-4609. PubMed ID: 28368394
[TBL] [Abstract][Full Text] [Related]
2. Curcumin-targeting pericellular serine protease matriptase role in suppression of prostate cancer cell invasion, tumor growth, and metastasis.
Cheng TS; Chen WC; Lin YY; Tsai CH; Liao CI; Shyu HY; Ko CJ; Tzeng SF; Huang CY; Yang PC; Hsiao PW; Lee MS
Cancer Prev Res (Phila); 2013 May; 6(5):495-505. PubMed ID: 23466486
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases.
Attiga FA; Fernandez PM; Weeraratna AT; Manyak MJ; Patierno SR
Cancer Res; 2000 Aug; 60(16):4629-37. PubMed ID: 10969817
[TBL] [Abstract][Full Text] [Related]
4. Androgen-Induced TMPRSS2 Activates Matriptase and Promotes Extracellular Matrix Degradation, Prostate Cancer Cell Invasion, Tumor Growth, and Metastasis.
Ko CJ; Huang CC; Lin HY; Juan CP; Lan SW; Shyu HY; Wu SR; Hsiao PW; Huang HP; Shun CT; Lee MS
Cancer Res; 2015 Jul; 75(14):2949-60. PubMed ID: 26018085
[TBL] [Abstract][Full Text] [Related]
5. HAI-2 suppresses the invasive growth and metastasis of prostate cancer through regulation of matriptase.
Tsai CH; Teng CH; Tu YT; Cheng TS; Wu SR; Ko CJ; Shyu HY; Lan SW; Huang HP; Tzeng SF; Johnson MD; Lin CY; Hsiao PW; Lee MS
Oncogene; 2014 Sep; 33(38):4643-52. PubMed ID: 24121274
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression.
Larkins TL; Nowell M; Singh S; Sanford GL
BMC Cancer; 2006 Jul; 6():181. PubMed ID: 16831226
[TBL] [Abstract][Full Text] [Related]
7. Matriptase is involved in ErbB-2-induced prostate cancer cell invasion.
Wu SR; Cheng TS; Chen WC; Shyu HY; Ko CJ; Huang HP; Teng CH; Lin CH; Johnson MD; Lin CY; Lee MS
Am J Pathol; 2010 Dec; 177(6):3145-58. PubMed ID: 20971737
[TBL] [Abstract][Full Text] [Related]
8. Activation of sphingosine kinase by lipopolysaccharide promotes prostate cancer cell invasion and metastasis via SphK1/S1PR4/matriptase.
Lee CF; Dang A; Hernandez E; Pong RC; Chen B; Sonavane R; Raj G; Kapur P; Lin HY; Wu SR; Ko CJ; Lo UG; Lee HY; Hsieh JT; Lee MS
Oncogene; 2019 Jul; 38(28):5580-5598. PubMed ID: 31152147
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2 inhibitor celecoxib augments chemotherapeutic drug-induced apoptosis by enhancing activation of caspase-3 and -9 in prostate cancer cells.
Dandekar DS; Lopez M; Carey RI; Lokeshwar BL
Int J Cancer; 2005 Jun; 115(3):484-92. PubMed ID: 15688368
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the function of matriptase and N-acetylglucosaminyltransferase V in prostate cancer metastasis.
Tsui KH; Chang PL; Feng TH; Chung LC; Sung HC; Juang HH
Anticancer Res; 2008; 28(4A):1993-9. PubMed ID: 18649738
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of the S1P
Filipenko I; Schwalm S; Reali L; Pfeilschifter J; Fabbro D; Huwiler A; Zangemeister-Wittke U
Biochim Biophys Acta; 2016 Nov; 1861(11):1840-1851. PubMed ID: 27616330
[TBL] [Abstract][Full Text] [Related]
12. The influence of matriptase-2 on prostate cancer in vitro: a possible role for β-catenin.
Webb SL; Sanders AJ; Mason MD; Jiang WG
Oncol Rep; 2012 Oct; 28(4):1491-7. PubMed ID: 22858929
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of matriptase by overexpression of bikunin attenuates cell invasion in prostate carcinoma cells.
Tsui KH; Chang PL; Feng TH; Chung LC; Hsu SY; Juang HH
Anticancer Res; 2008; 28(4A):1977-83. PubMed ID: 18649735
[TBL] [Abstract][Full Text] [Related]
14. Sulindac sulfone inhibits K-ras-dependent cyclooxygenase-2 expression in human colon cancer cells.
Taylor MT; Lawson KR; Ignatenko NA; Marek SE; Stringer DE; Skovan BA; Gerner EW
Cancer Res; 2000 Dec; 60(23):6607-10. PubMed ID: 11118042
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of cyclooxygenase-2 activity by celecoxib does not lead to radiosensitization of human prostate cancer cells in vitro.
Ohneseit PA; Krebiehl G; Dittmann K; Kehlbach R; Rodemann HP
Radiother Oncol; 2007 Feb; 82(2):229-38. PubMed ID: 17207548
[TBL] [Abstract][Full Text] [Related]
16. Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation.
Sanders AJ; Parr C; Martin TA; Lane J; Mason MD; Jiang WG
J Cell Physiol; 2008 Sep; 216(3):780-9. PubMed ID: 18449907
[TBL] [Abstract][Full Text] [Related]
17. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model.
Narayanan BA; Narayanan NK; Pittman B; Reddy BS
Clin Cancer Res; 2004 Nov; 10(22):7727-37. PubMed ID: 15570007
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of thromboxane synthase in prostate carcinoma: role in tumor cell motility.
Nie D; Che M; Zacharek A; Qiao Y; Li L; Li X; Lamberti M; Tang K; Cai Y; Guo Y; Grignon D; Honn KV
Am J Pathol; 2004 Feb; 164(2):429-39. PubMed ID: 14742249
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase 2 Promotes Proliferation and Invasion in Ovarian Cancer Cells via the PGE2/NF-κB Pathway.
Zhang X; Yan K; Deng L; Liang J; Liang H; Feng D; Ling B
Cell Transplant; 2019 Dec; 28(1_suppl):1S-13S. PubMed ID: 31822119
[TBL] [Abstract][Full Text] [Related]
20. Matriptase-2/NR4A3 axis switches TGF-β action toward suppression of prostate cancer cell invasion, tumor growth, and metastasis.
Lin HY; Ko CJ; Lo TY; Wu SR; Lan SW; Huang CA; Lin YC; Lin HH; Tu HF; Lee CF; Hsiao PW; Huang HP; Chen MJ; Chang KH; Lee MS
Oncogene; 2022 May; 41(20):2833-2845. PubMed ID: 35418692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
